MNQ derivative D19 alleviates LPS-induced inflammation and oxidative stress in sheep follicular granulosa cells through the GPX4-mediated ferroptosis.

阅读:4
作者:Chen Chunlu, Lu Jia, Qu Yuhan, Dong Jianhua, Hong Yihao, Ren Yongping, Jiang Shouqing, Baptista Rafael, Wang Dong, Mur Luis Aj, Lyu Lihua
INTRODUCTION: 2-methoxy-1,4-naphthoquinone (MNQ), a compound derived from Impatiens balsamina L., is recognized for its anti-inflammatory and antioxidant properties. However, the effects of D19, a derivative of MNQ, remain unexplored. This study aimed to elucidate the protective effect of D19 against lipopolysaccharide (LPS)-induced follicular granulosa cells (GCs) dysfunction in sheep and its underlying molecular mechanisms. METHODS: An in vitro model of GCs injury was established using LPS to induce inflammation and oxidative stress. The effects of D19 were evaluated by examining inflammatory response, oxidative stress, ferroptosis and steroidogenesis following treatment. Gene interference was applied to knock down GPX4 expression to validate its role in the protective mechanism of D19. RESULTS: D19 attenuated LPS-induced ferroptosis in GCs by restoring the expression of the key ferroptosis regulator GPX4. Subsequently, interfering with GPX4 activated NF-κB and upregulated the expression of inflammatory factors (TNF-α, IL-1β, IL-6) while disrupting NRF2 and inhibiting the expression of antioxidant-related factors (CAT, GSH-PX, SOD2). D19 effectively protected GCs from GPX4 deficiency-induced inflammation and oxidative damage. Furthermore, D19 mitigated ferroptosis caused by GPX4 deficiency and maintained iron metabolic homeostasis by restoring the morphology of GCs, increasing mitochondrial membrane potential, decreasing the accumulation of Fe(2+) and lipid peroxides, and promoting the expression of GPX4 and FTH1. D19 also improved steroid hormone secretion abnormalities caused by GPX4 deficiency. DISCUSSION: These results demonstrate that D19 protects sheep follicular GCs from LPS-induced damage by modulating the GPX4-mediated ferroptosis signaling pathway, providing new potential drugs and therapeutic targets for addressing GCs dysfunction and follicular developmental abnormalities.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。